Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioharvest Sciences (BHST) EBT (2023 - 2025)

Historic EBT for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to -$2.4 million.

  • Bioharvest Sciences' EBT rose 888.81% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.7 million, marking a year-over-year decrease of 33126.38%. This contributed to the annual value of -$12.9 million for FY2024, which is 271.41% down from last year.
  • As of Q3 2025, Bioharvest Sciences' EBT stood at -$2.4 million, which was up 888.81% from -$4.0 million recorded in Q2 2025.
  • In the past 5 years, Bioharvest Sciences' EBT registered a high of $7.2 million during Q4 2023, and its lowest value of -$6.6 million during Q1 2024.
  • Over the past 3 years, Bioharvest Sciences' median EBT value was -$2.4 million (recorded in 2025), while the average stood at -$988400.0.
  • Data for Bioharvest Sciences' EBT shows a peak YoY increase of 6505.09% (in 2025) and a maximum YoY decrease of 48820.96% (in 2025) over the last 5 years.
  • Bioharvest Sciences' EBT (Quarter) stood at $7.2 million in 2023, then tumbled by 140.75% to -$2.9 million in 2024, then rose by 16.89% to -$2.4 million in 2025.
  • Its last three reported values are -$2.4 million in Q3 2025, -$4.0 million for Q2 2025, and -$2.3 million during Q1 2025.